Further investigations into the expression level of SOX11, as well as the expression of its effectors in relation to the regulation of mesenchymal state, multipotency and stemness may lead to ways of stratifying and eventually targeting distinct breast cancer subtypes as SOX11 is associated with an elevated risk of developing metastases and may require more aggressive therapies. Here, SOX11 is linked to breast carcinoma.